Janux Therapeutics (JANX) Prepaid Assets (2020 - 2026)
Janux Therapeutics (JANX) reported Prepaid Assets of $893000.0 for Q1 2026, down 68.95% year-over-year from $2.9 million in Q1 2025, and down 51.83% quarter-over-quarter from $1.9 million in Q4 2025.
Janux Therapeutics (JANX) Prepaid Assets (2020 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has 7 years of Prepaid Assets data on file, last reported at $893000.0 in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $893000.0, down 68.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $893000.0 (down 68.95% YoY), and the FY2025 annual result was $1.9 million, down 21.24% from the prior year.
- Prepaid Assets declined to $893000.0 in Q1 2026 per JANX's latest filing, from $1.9 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $6.0 million in Q2 2023 and troughed at $893000.0 in Q1 2026.
- A 5-year average of $3.1 million and a median of $2.7 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2026: Prepaid Assets jumped 164.02% in 2022, then sank 68.95% in 2026.
- A 5-year view of Prepaid Assets shows it stood at $5.4 million in 2022, then plunged by 57.26% to $2.3 million in 2023, then climbed by 1.55% to $2.4 million in 2024, then dropped by 21.24% to $1.9 million in 2025, then plunged by 51.83% to $893000.0 in 2026.
- Business Quant data shows JANX's Prepaid Assets at $893000.0 in Q1 2026, $1.9 million in Q4 2025, and $1.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Janux Therapeutics | 892.99 Mn | 892.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 893,000.00 |
| Dec 31, 2025 | 1.85 Mn |
| Sep 30, 2025 | 1.19 Mn |
| Jun 30, 2025 | 1.61 Mn |
| Mar 31, 2025 | 2.88 Mn |
| Dec 31, 2024 | 2.35 Mn |
| Sep 30, 2024 | 2.68 Mn |
| Jun 30, 2024 | 2.41 Mn |
| Mar 31, 2024 | 1.84 Mn |
| Dec 31, 2023 | 2.32 Mn |
| Sep 30, 2023 | 5.48 Mn |
| Jun 30, 2023 | 6.01 Mn |
| Mar 31, 2023 | 3.77 Mn |
| Dec 31, 2022 | 5.42 Mn |
| Sep 30, 2022 | 5.07 Mn |
| Jun 30, 2022 | 3.77 Mn |
| Mar 31, 2022 | 3.45 Mn |
| Dec 31, 2021 | 2.05 Mn |
| Sep 30, 2021 | 2.08 Mn |
| Jun 30, 2021 | 2.04 Mn |